世界のBCG結核（TB）ワクチン市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global BCG Tuberculosis (TB) Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z02052
• 出版社/出版日：GlobalInfoResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療・医薬品

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料では、BCG結核（TB）ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。BCG結核（TB）ワクチンの種類別市場規模（免疫BCG、治療BCG）、用途別市場規模（病院、診療所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・BCG結核（TB）ワクチンの市場概要
・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、Sanofi Pasteur、Japan BCG Lab、China National Biotec、Serum Institute of India、Intervax、GSBPL
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年：免疫BCG、治療BCG
・用途別分析2016年-2026年：病院、診療所
・BCG結核（TB）ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ
・BCG結核（TB）ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア
・BCG結核（TB）ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア
・BCG結核（TB）ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン
・BCG結核（TB）ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The BCG Tuberculosis (TB) Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global BCG Tuberculosis (TB) Vaccine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global BCG Tuberculosis (TB) Vaccine market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
BCG Tuberculosis (TB) Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Immune BCG
Therapy BCG

Market segment by Application can be divided into
Hospital
Clinic

The key market players for global BCG Tuberculosis (TB) Vaccine market are listed below:
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 BCG Tuberculosis (TB) Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global BCG Tuberculosis (TB) Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Immune BCG
1.2.3 Therapy BCG
1.3 Market Analysis by Application
1.3.1 Overview: Global BCG Tuberculosis (TB) Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.4 Global BCG Tuberculosis (TB) Vaccine Market Size & Forecast
1.4.1 Global BCG Tuberculosis (TB) Vaccine Sales in Value (2016-2026))
1.4.2 Global BCG Tuberculosis (TB) Vaccine Sales in Volume (2016-2026)
1.4.3 Global BCG Tuberculosis (TB) Vaccine Price by Type (2016-2026) & (USD/Unit)
1.5 Global BCG Tuberculosis (TB) Vaccine Production Capacity Analysis
1.5.1 Global BCG Tuberculosis (TB) Vaccine Total Production Capacity (2016-2026)
1.5.2 Global BCG Tuberculosis (TB) Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 BCG Tuberculosis (TB) Vaccine Market Drivers
1.6.2 BCG Tuberculosis (TB) Vaccine Market Restraints
1.6.3 BCG Tuberculosis (TB) Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck BCG Tuberculosis (TB) Vaccine Product and Services
2.1.4 Merck BCG Tuberculosis (TB) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Sanofi Pasteur
2.2.1 Sanofi Pasteur Details
2.2.2 Sanofi Pasteur Major Business
2.2.3 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Product and Services
2.2.4 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Japan BCG Lab
2.3.1 Japan BCG Lab Details
2.3.2 Japan BCG Lab Major Business
2.3.3 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Product and Services
2.3.4 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 China National Biotec
2.4.1 China National Biotec Details
2.4.2 China National Biotec Major Business
2.4.3 China National Biotec BCG Tuberculosis (TB) Vaccine Product and Services
2.4.4 China National Biotec BCG Tuberculosis (TB) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Serum Institute of India
2.5.1 Serum Institute of India Details
2.5.2 Serum Institute of India Major Business
2.5.3 Serum Institute of India BCG Tuberculosis (TB) Vaccine Product and Services
2.5.4 Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Intervax
2.6.1 Intervax Details
2.6.2 Intervax Major Business
2.6.3 Intervax BCG Tuberculosis (TB) Vaccine Product and Services
2.6.4 Intervax BCG Tuberculosis (TB) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 GSBPL
2.7.1 GSBPL Details
2.7.2 GSBPL Major Business
2.7.3 GSBPL BCG Tuberculosis (TB) Vaccine Product and Services
2.7.4 GSBPL BCG Tuberculosis (TB) Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 BCG Tuberculosis (TB) Vaccine Sales by Manufacturer
3.1 Global BCG Tuberculosis (TB) Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in BCG Tuberculosis (TB) Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 BCG Tuberculosis (TB) Vaccine Manufacturer Market Share
3.4.2 Top 6 BCG Tuberculosis (TB) Vaccine Manufacturer Market Share
3.5 Global BCG Tuberculosis (TB) Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and BCG Tuberculosis (TB) Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global BCG Tuberculosis (TB) Vaccine Market Size by Region
4.1.1 Global BCG Tuberculosis (TB) Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Region (2016-2026)
4.2 North America BCG Tuberculosis (TB) Vaccine Revenue (2016-2026)
4.3 Europe BCG Tuberculosis (TB) Vaccine Revenue (2016-2026)
4.4 Asia-Pacific BCG Tuberculosis (TB) Vaccine Revenue (2016-2026)
4.5 South America BCG Tuberculosis (TB) Vaccine Revenue (2016-2026)
4.6 Middle East and Africa BCG Tuberculosis (TB) Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global BCG Tuberculosis (TB) Vaccine Sales in Volume by Type (2016-2026)
5.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Type (2016-2026)
5.3 Global BCG Tuberculosis (TB) Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global BCG Tuberculosis (TB) Vaccine Sales in Volume by Application (2016-2026)
6.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Application (2016-2026)
6.3 Global BCG Tuberculosis (TB) Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America BCG Tuberculosis (TB) Vaccine Sales by Type (2016-2026)
7.2 North America BCG Tuberculosis (TB) Vaccine Sales by Application (2016-2026)
7.3 North America BCG Tuberculosis (TB) Vaccine Market Size by Country
7.3.1 North America BCG Tuberculosis (TB) Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America BCG Tuberculosis (TB) Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe BCG Tuberculosis (TB) Vaccine Sales by Type (2016-2026)
8.2 Europe BCG Tuberculosis (TB) Vaccine Sales by Application (2016-2026)
8.3 Europe BCG Tuberculosis (TB) Vaccine Market Size by Country
8.3.1 Europe BCG Tuberculosis (TB) Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe BCG Tuberculosis (TB) Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific BCG Tuberculosis (TB) Vaccine Market Size by Region
9.3.1 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific BCG Tuberculosis (TB) Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America BCG Tuberculosis (TB) Vaccine Sales by Type (2016-2026)
10.2 South America BCG Tuberculosis (TB) Vaccine Sales by Application (2016-2026)
10.3 South America BCG Tuberculosis (TB) Vaccine Market Size by Country
10.3.1 South America BCG Tuberculosis (TB) Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America BCG Tuberculosis (TB) Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa BCG Tuberculosis (TB) Vaccine Market Size by Country
11.3.1 Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa BCG Tuberculosis (TB) Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 BCG Tuberculosis (TB) Vaccine Typical Distributors
12.3 BCG Tuberculosis (TB) Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global BCG Tuberculosis (TB) Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global BCG Tuberculosis (TB) Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck BCG Tuberculosis (TB) Vaccine Product and Services
Table 6. Merck BCG Tuberculosis (TB) Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Pasteur Major Business
Table 9. Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Product and Services
Table 10. Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Japan BCG Lab Basic Information, Manufacturing Base and Competitors
Table 12. Japan BCG Lab Major Business
Table 13. Japan BCG Lab BCG Tuberculosis (TB) Vaccine Product and Services
Table 14. Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. China National Biotec Basic Information, Manufacturing Base and Competitors
Table 16. China National Biotec Major Business
Table 17. China National Biotec BCG Tuberculosis (TB) Vaccine Product and Services
Table 18. China National Biotec BCG Tuberculosis (TB) Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 20. Serum Institute of India Major Business
Table 21. Serum Institute of India BCG Tuberculosis (TB) Vaccine Product and Services
Table 22. Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Intervax Basic Information, Manufacturing Base and Competitors
Table 24. Intervax Major Business
Table 25. Intervax BCG Tuberculosis (TB) Vaccine Product and Services
Table 26. Intervax BCG Tuberculosis (TB) Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. GSBPL Basic Information, Manufacturing Base and Competitors
Table 28. GSBPL Major Business
Table 29. GSBPL BCG Tuberculosis (TB) Vaccine Product and Services
Table 30. GSBPL BCG Tuberculosis (TB) Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global BCG Tuberculosis (TB) Vaccine Sales by Manufacturer (2019-2021e) & (K Units)
Table 32. Global BCG Tuberculosis (TB) Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in BCG Tuberculosis (TB) Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global BCG Tuberculosis (TB) Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and BCG Tuberculosis (TB) Vaccine Production Site of Key Manufacturer
Table 36. Global BCG Tuberculosis (TB) Vaccine Sales by Region (2016-2021e) & (K Units)
Table 37. Global BCG Tuberculosis (TB) Vaccine Sales by Region (2021-2026) & (K Units)
Table 38. Global BCG Tuberculosis (TB) Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 39. Global BCG Tuberculosis (TB) Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 40. Global BCG Tuberculosis (TB) Vaccine Sales by Type (2016-2021e) & (K Units)
Table 41. Global BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. Global BCG Tuberculosis (TB) Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 43. Global BCG Tuberculosis (TB) Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 44. Global BCG Tuberculosis (TB) Vaccine Price by Type (2016-2021e) & (USD/Unit)
Table 45. Global BCG Tuberculosis (TB) Vaccine Price by Type (2021-2026) & (USD/Unit)
Table 46. Global BCG Tuberculosis (TB) Vaccine Sales by Application (2016-2021e) & (K Units)
Table 47. Global BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (K Units)
Table 48. Global BCG Tuberculosis (TB) Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 49. Global BCG Tuberculosis (TB) Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 50. Global BCG Tuberculosis (TB) Vaccine Price by Application (2016-2021e) & (USD/Unit)
Table 51. Global BCG Tuberculosis (TB) Vaccine Price by Application (2021-2026) & (USD/Unit)
Table 52. North America BCG Tuberculosis (TB) Vaccine Sales by Country (2016-2021e) & (K Units)
Table 53. North America BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026) & (K Units)
Table 54. North America BCG Tuberculosis (TB) Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 55. North America BCG Tuberculosis (TB) Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 56. North America BCG Tuberculosis (TB) Vaccine Sales by Type (2016-2021e) & (K Units)
Table 57. North America BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (K Units)
Table 58. North America BCG Tuberculosis (TB) Vaccine Sales by Application (2016-2021e) & (K Units)
Table 59. North America BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (K Units)
Table 60. Europe BCG Tuberculosis (TB) Vaccine Sales by Country (2016-2021e) & (K Units)
Table 61. Europe BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026) & (K Units)
Table 62. Europe BCG Tuberculosis (TB) Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 63. Europe BCG Tuberculosis (TB) Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 64. Europe BCG Tuberculosis (TB) Vaccine Sales by Type (2016-2021e) & (K Units)
Table 65. Europe BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (K Units)
Table 66. Europe BCG Tuberculosis (TB) Vaccine Sales by Application (2016-2021e) & (K Units)
Table 67. Europe BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (K Units)
Table 68. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales by Region (2016-2021e) & (K Units)
Table 69. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales by Region (2021-2026) & (K Units)
Table 70. Asia-Pacific BCG Tuberculosis (TB) Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 71. Asia-Pacific BCG Tuberculosis (TB) Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales by Type (2016-2021e) & (K Units)
Table 73. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (K Units)
Table 74. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales by Application (2016-2021e) & (K Units)
Table 75. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (K Units)
Table 76. South America BCG Tuberculosis (TB) Vaccine Sales by Country (2016-2021e) & (K Units)
Table 77. South America BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026) & (K Units)
Table 78. South America BCG Tuberculosis (TB) Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 79. South America BCG Tuberculosis (TB) Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 80. South America BCG Tuberculosis (TB) Vaccine Sales by Type (2016-2021e) & (K Units)
Table 81. South America BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (K Units)
Table 82. South America BCG Tuberculosis (TB) Vaccine Sales by Application (2016-2021e) & (K Units)
Table 83. South America BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (K Units)
Table 84. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales by Country (2016-2021e) & (K Units)
Table 85. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026) & (K Units)
Table 86. Middle East & Africa BCG Tuberculosis (TB) Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 87. Middle East & Africa BCG Tuberculosis (TB) Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 88. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales by Type (2016-2021e) & (K Units)
Table 89. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (K Units)
Table 90. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales by Application (2016-2021e) & (K Units)
Table 91. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (K Units)
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. BCG Tuberculosis (TB) Vaccine Typical Distributors
Table 95. BCG Tuberculosis (TB) Vaccine Typical Customers
List of Figures
Figure 1. BCG Tuberculosis (TB) Vaccine Picture
Figure 2. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Type in 2020
Figure 3. Immune BCG
Figure 4. Therapy BCG
Figure 5. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Global BCG Tuberculosis (TB) Vaccine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global BCG Tuberculosis (TB) Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States BCG Tuberculosis (TB) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada BCG Tuberculosis (TB) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico BCG Tuberculosis (TB) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany BCG Tuberculosis (TB) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France BCG Tuberculosis (TB) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom BCG Tuberculosis (TB) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia BCG Tuberculosis (TB) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy BCG Tuberculosis (TB) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China BCG Tuberculosis (TB) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan BCG Tuberculosis (TB) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea BCG Tuberculosis (TB) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India BCG Tuberculosis (TB) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia BCG Tuberculosis (TB) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia BCG Tuberculosis (TB) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil BCG Tuberculosis (TB) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt BCG Tuberculosis (TB) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia BCG Tuberculosis (TB) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa BCG Tuberculosis (TB) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey BCG Tuberculosis (TB) Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global BCG Tuberculosis (TB) Vaccine Sales (2016-2026) & (K Units)
Figure 30. Global BCG Tuberculosis (TB) Vaccine Production Capacity (2016-2026) & (K Units)
Figure 31. Global BCG Tuberculosis (TB) Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. BCG Tuberculosis (TB) Vaccine Market Drivers
Figure 33. BCG Tuberculosis (TB) Vaccine Market Restraints
Figure 34. BCG Tuberculosis (TB) Vaccine Market Trends
Figure 35. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Manufacturer in 2020
Figure 36. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Manufacturer in 2020
Figure 37. BCG Tuberculosis (TB) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 BCG Tuberculosis (TB) Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 BCG Tuberculosis (TB) Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 40. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Region (2016-2026)
Figure 41. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Region (2016-2026)
Figure 42. North America BCG Tuberculosis (TB) Vaccine Revenue (2016-2026) & (USD Million)
Figure 43. Europe BCG Tuberculosis (TB) Vaccine Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific BCG Tuberculosis (TB) Vaccine Revenue (2016-2026) & (USD Million)
Figure 45. South America BCG Tuberculosis (TB) Vaccine Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa BCG Tuberculosis (TB) Vaccine Revenue (2016-2026) & (USD Million)
Figure 47. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Type (2016-2026)
Figure 48. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Type (2016-2026)
Figure 49. Global BCG Tuberculosis (TB) Vaccine Price by Type (2016-2026) & (USD/Unit)
Figure 50. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Application (2016-2026)
Figure 51. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Application (2016-2026)
Figure 52. Global BCG Tuberculosis (TB) Vaccine Price by Application (2016-2026) & (USD/Unit)
Figure 53. North America BCG Tuberculosis (TB) Vaccine Sales Market Share by Country (2016-2026)
Figure 54. North America BCG Tuberculosis (TB) Vaccine Revenue Market Share by Country (2016-2026)
Figure 55. North America BCG Tuberculosis (TB) Vaccine Sales Market Share by Type (2016-2026)
Figure 56. North America BCG Tuberculosis (TB) Vaccine Sales Market Share by Application (2016-2026)
Figure 57. Europe BCG Tuberculosis (TB) Vaccine Sales Market Share by Country (2016-2026)
Figure 58. Europe BCG Tuberculosis (TB) Vaccine Revenue Market Share by Country (2016-2026)
Figure 59. Europe BCG Tuberculosis (TB) Vaccine Sales Market Share by Type (2016-2026)
Figure 60. Europe BCG Tuberculosis (TB) Vaccine Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific BCG Tuberculosis (TB) Vaccine Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Market Share by Application (2016-2026)
Figure 65. South America BCG Tuberculosis (TB) Vaccine Sales Market Share by Country (2016-2026)
Figure 66. South America BCG Tuberculosis (TB) Vaccine Revenue Market Share by Country (2016-2026)
Figure 67. South America BCG Tuberculosis (TB) Vaccine Sales Market Share by Type (2016-2026)
Figure 68. South America BCG Tuberculosis (TB) Vaccine Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa BCG Tuberculosis (TB) Vaccine Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source

Global Human Papillomavirus (HPV) Vaccines Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z07261 2021年4月 105Pages
当調査資料では、ヒトパピローマウイルス（HPV）ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ヒトパピローマウイルス（HPV）ワクチンの種類別市場規模（2価ワクチン、4価ワクチン）、用途別市場規模（研究所、製薬・バイオテクノロジー企業、その他...

世界のポリオ（ポリオ）ワクチン市場 2021：企業別、地域別、種類・用途別

Global Polio (Poliomyelitis) Vaccines Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z11096 2021年4月 108Pages
当調査資料では、ポリオ（ポリオ）ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ポリオ（ポリオ）ワクチンの種類別市場規模（不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV））、用途別市場規模（研究所、製薬・バイオテクノロジー企業、その...

世界の結核治療市場 2021：企業別、地域別、種類・用途別

Global Tuberculosis Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z14260 2021年4月 103Pages
当調査資料では、結核治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。結核治療の種類別市場規模（イソニアジド、リファンピン、ピラジナミド、ヒドラジン誘導体、その他抗尿細管薬、エタンブトール、その他）、用途別市場規模（病院、薬局、診療所、その他）、地域...

世界の結核治療薬市場 2021：企業別、地域別、種類・用途別

Global Tuberculosis Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z14259 2021年4月 100Pages
当調査資料では、結核治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。結核治療薬の種類別市場規模（一次薬物療法、二次薬物療法、併用薬物療法）、用途別市場規模（病院、私立診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本...

世界のアデノウイルスワクチン市場 2021：企業別、地域別、種類・用途別

Global Adenovirus Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z00345 2021年4月 104Pages
当調査資料では、アデノウイルスワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アデノウイルスワクチンの種類別市場規模（タイプ4ワクチン、タイプ7ワクチン）、用途別市場規模（研究所、製薬・バイオテクノロジー企業、その他）、地域別市場規模（北米、ア...

世界の肺炎球菌多価ワクチン市場 2021：企業別、地域別、種類・用途別

Global Pneumococcal Vaccine Polyvalent Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z11073 2021年4月 104Pages
当調査資料では、肺炎球菌多価ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。肺炎球菌多価ワクチンの種類別市場規模（プレベナー13、肺炎球菌23）、用途別市場規模（18歳以下、19〜64歳、65歳以上）、地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の経口コレラワクチン市場 2021：企業別、地域別、種類・用途別

Global Oral Cholera Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z10297 2021年4月 107Pages
当調査資料では、経口コレラワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。経口コレラワクチンの種類別市場規模（Shanchol、Dukoral、Vaxchora、その他）、用途別市場規模（病院、研究所＆学術研究所、製薬・バイオテクノロジー企業、...

世界の水痘ワクチン市場 2021：企業別、地域別、種類・用途別

Global Chickenpox Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z03084 2021年4月 107Pages
当調査資料では、水痘ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。水痘ワクチンの種類別市場規模（一価ワクチン、混合ワクチン）、用途別市場規模（子供用、大人用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、...

世界のクロストリジウムワクチン市場 2021：企業別、地域別、種類・用途別

Global Clostridium Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z03271 2021年4月 100Pages
当調査資料では、クロストリジウムワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。クロストリジウムワクチンの種類別市場規模（PF-06425090、VLA84）、用途別市場規模（獣医病院、獣医クリニック、その他）、地域別市場規模（北米、アメリカ、...

世界のコレラワクチン（経口用）市場 2021：企業別、地域別、種類・用途別

Global Cholera Vaccine (Oral Route) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z03142 2021年4月 101Pages
当調査資料では、コレラワクチン（経口用）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。コレラワクチン（経口用）の種類別市場規模（Shanchol、Dukoral、Vaxchora、その他）、用途別市場規模（病院、研究所、製薬・バイオテクノロジー企業、...

世界の結核治療薬市場 2021：企業別、地域別、種類・用途別 The Tuberculosis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
世界の結核治療市場 2021：企業別、地域別、種類・用途別 The Tuberculosis Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
世界の抗結核治療市場規模・現状・予測（2021年-2027年） Tuberculosis (TB) is a disease affecting the population across the world. Although tuberculosis is a curable disease, it still remains one of the most common causes of death among adults, particularly in the emerging economies. Market Analysis and Insights: Global Anti-tuberculosis Therapeutics Mark…
世界の新型コロナウイルス感染症RNAワクチン市場規模・現状・予測（2021年-2027年） RNA vaccines are leading the way in vaccines because they are particularly well suited to rapid development.Although no RNA vaccine has yet been approved, the threat of a pandemic is a great incentive to accelerate its progress.RNA vaccines consist of mrna strands.They are injected into the body, us…
世界のTBワクチン治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global TB Vaccine Treatment Market The global TB Vaccine Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…